Completed NA INTERVENTIONAL 2-arm NCT03329742

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

A Pilot Feasibility Study of Sipuleucel-T vs. Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC)

Sponsor: Indiana University

Conditions Prostate Cancer Recurrent

Interventions Control protein diet Low protein diet

Updated 10 times since 2017 Last updated: Mar 25, 2021 Started: Dec 19, 2017 Primary completion: Oct 21, 2019 Completion: May 5, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Prostate Cancer Recurrent and is currently completed. Indiana University leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Active Not Recruiting NA
Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

Aug 2020 — Oct 2020 [monthly]

Recruiting NA
Oct 2019 — Aug 2020 [monthly]

Recruiting NA
Jun 2018 — Oct 2019 [monthly]

Recruiting NA
Apr 2018 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University
Indiana University School of Medicine

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States